Please Wait.....
Report
North America Branded Generics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
Market Report I 2022-09-26 I 169 Pages I The Insight Partners
The branded generics market in North America is expected to grow from US$ 73.15 billion in 2022 to US$ 126.24 billion by 2028; it is estimated to grow at a CAGR of 9.5% from 2022 to 2028.
The increasing penetration of branded generics drives the growth of the North America branded generics market. According to a report by VOXEU, with healthcare budgets under pressure, switching to branded generics seems a natural cost saver. Branded generics are cheaper alternatives to branded medicines. Additionally, as per the data of FDA, more than 90% of the prescription in US were filled by generic drugs during year 2020. Further, according to the Association of the Accessible Medicine, in year 2020, the generic and biosimilar drugs saved US$ 338 billion in US. Moreover, healthcare expenditure grew by 9.7% during the same year in US and reached US$ 4.1 trillion. Further, a savings of US$ 2.2 trillion is observed in healthcare expenditure during the last decade in US due to the availability of low-cost generics.
Further, the Association for Accessible Medicines report states that nearly 4 billion generic prescriptions were dispensed in 2018. According to the HSRII report, the US is the largest pharmaceutical market in the world (US$ 325 billion), accounting for one-third of the overall pharmaceutical market, with generics accounting for 84% in terms of volume of sales and 28% in terms of sales value. Furthermore, branded generics utilization has increased among the population due to savings provided low cost alternatives and by the healthcare reimbursement system. On average, in 2019, the use of generic medicines saved US$ 93 billion in Medicare savings and US$ 48.5 billion in savings to Medicaid. Hence, the rising penetration of generics stimulates the growth of the overall branded generics market.
By introducing new features and technologies, vendors in the North America branded generics market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market at a good CAGR during the forecast period.
North America Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)
North America Branded Generics Market Segmentation
The North America branded generics market is segmented on the basis of therapeutic application, distribution channel, drug class, formulation type, and country. Based on therapeutic application, the market is segmented into oncology, cardiovascular diseases, diabetes, neurology, gastrointestinal diseases, dermatology diseases, and analgesics and anti-inflammatory. In 2022, the others segment holds the largest share of the market. The market, by distribution channel, is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. The retail pharmacies segment holds the largest share of the market in 2022. The North America branded generics market, based on drug class, is segmented into alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptic, and others. The others segment holds the largest share of the market in 2022. The market, based on formulation type, is segmented into oral, parenteral, topical, and other. In 2022, the oral segment holds the largest share of the market. Based on country, the North America branded generics market is segmented into the US, Canada, and Mexico. The US holds the largest market share in 2022.
Aspen Holdings, AstraZeneca, Bausch Health (Valeant Pharmaceuticals), Dr. Reddy's Laboratories Inc., GlaxoSmithKline plc, Hetero, Lupin, MYLAN N.V., Par Pharmaceuticals, Sandoz International Gmbh, Sanofi, and TEVA PHARMACEUTICAL INDUSTRIES LTD. are among the leading companies in the branded generics market operating in this region.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Branded Generics Market - By Therapeutic Application
1.3.2 North America Branded Generics Market - By Distribution Channel
1.3.3 North America Branded Generics Market - By Drug Class
1.3.4 North America Branded Generics Market - By Formulation Type
1.3.5 North America Branded Generics Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Branded Generics Market - Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Branded Generics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Penetration of Branded Generics
5.1.2 Surging Government Initiatives for Promoting Branded Generics
5.2 Market Restraints
5.2.1 Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications
5.3 Market Opportunities
5.3.1 Product Differentiation Creating Opportunities
5.4 Future Trends
5.4.1 Encouraging Utility of Branded Generics by Healthcare Providers and Professionals
5.5 Impact Analysis
6. Branded Generics Market- North America Analysis
6.1 North America Branded Generics Market Revenue Forecast and Analysis
6.2 North America Branded Generics Market, By Country - Forecast and Analysis
7. North America Branded Generics Market Revenue and Forecast To 2028- by Therapeutic Application
7.1 Overview
7.2 North America Branded Generics Market Revenue Share, By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology Market Revenue and Forecast to 2028 (US$ Billion)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.5 Diabetes
7.5.1 Overview
7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Billion)
7.6 Neurology
7.6.1 Overview
7.6.2 Neurology Market Revenue and Forecast to 2028 (US$ Billion)
7.7 Gastrointestinal Diseases
7.7.1 Overview
7.7.2 Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.8 Dermatology Diseases
7.8.1 Overview
7.8.2 Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.9 Analgesics and Anti-Inflammatory
7.9.1 Overview
7.9.2 Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)
7.10 Others
7.10.1 Overview
7.10.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
8. North America Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel
8.1 North America Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)
8.2 Hospital Pharmacies
8.2.1 Overview
8.2.2 Hospital Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
8.3 Retail Pharmacies
8.3.1 Overview
8.3.2 Retail Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
8.4 Online Pharmacies
8.4.1 Overview
8.4.2 Online Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
8.5 Drug Stores
8.5.1 Overview
8.5.2 Drug Stores: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9. North America Branded Generics Market Analysis and Forecast to 2028 by Drug Class
9.1 North America Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)
9.2 Alkylating Agents
9.2.1 Overview
9.2.2 Alkylating Agents: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.3 Antimetabolites
9.3.1 Overview
9.3.2 Antimetabolites: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.4 Hormones
9.4.1 Overview
9.4.2 Hormones: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.5 Anti-hypertensive
9.5.1 Overview
9.5.2 Anti-hypertensive: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.6 Lipid Lowering Drugs
9.6.1 Overview
9.6.2 Lipid Lowering Drugs: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.7 Anti-Depressants
9.7.1 Overview
9.7.2 Anti-Depressants: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.8 Anti-psychotics
9.8.1 Overview
9.8.2 Anti-psychotics: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.9 Anti-epileptic
9.9.1 Overview
9.9.2 Anti-epileptic: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
9.10 Others
9.10.1 Overview
9.10.2 Others: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
10. North America Branded Generics Market Analysis and Forecast to 2028 - by Formulation Type
10.1 Overview
10.2 North America Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)
10.3 Oral
10.3.1 Overview
10.3.2 Oral Market Revenue and Forecast to 2028 (US$ Billion)
10.4 Parenteral
10.4.1 Overview
10.4.2 Parenteral Market Revenue and Forecast to 2028 (US$ Billion)
10.5 Topical
10.5.1 Overview
10.5.2 Topical Market Revenue and Forecast to 2028 (US$ Billion)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
11. North America Branded Generics Market Revenue and Forecasts to 2028 Country Analysis
11.1 Overview
11.1.1 North America: Branded Generics Market, by Country, 2022 & 2028 (%)
11.1.1.1 US: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.1.1.1 Overview
11.1.1.1.2 US: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.1.1.3 US: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.1.1.1.4 US: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.1.1.1.5 US: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.1.1.1.6 US: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.1.1.2 Canada: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2.1 Overview
11.1.1.2.2 Canada: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2.3 Canada: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.1.1.2.4 Canada: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.1.1.2.5 Canada: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.1.1.2.6 Canada: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
11.1.1.3 Mexico: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3.1 Overview
11.1.1.3.2 Mexico: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3.3 Mexico: Branded Generics Market, by Therapeutic Application, 2019-2028 (US$ Billion)
11.1.1.3.4 Mexico: Branded Generics Market, by Distribution Channel, 2019-2028 (US$ Billion)
11.1.1.3.5 Mexico: Branded Generics Market, by Drug Class, 2019-2028 (US$ Billion)
11.1.1.3.6 Mexico: Branded Generics Market, by Formulation Type, 2019-2028 (US$ Billion)
12. Branded Generics Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MYLAN N.V.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bausch Health Companies Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Lupin
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Sanofi
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ASTRAZENECA PLC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Dr. Reddy's Laboratories
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Par Pharmaceuticals, INC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Sandoz International GMBH
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Aspen Holdings
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Hetero
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 2. US Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 3. US Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 4. US Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 5. Canada: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 6. Canada Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 7. Canada Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 8. Canada Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 9. Mexico: Branded Generics Market, by Therapeutic Application - Revenue and Forecast to 2028 (US$ Billion)
Table 10. Mexico Branded Generics Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Billion)
Table 11. Mexico Branded Generics Market, by Drug Class - Revenue and Forecast to 2028 (US$ Billion)
Table 12. Mexico Branded Generics Market, by Formulation Type - Revenue and Forecast to 2028 (US$ Billion)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic Developments Done By Companies
Table 15. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Branded Generics Market Segmentation
Figure 2. North America Branded Generics Market, By Country
Figure 3. North America Branded Generics Market Overview
Figure 4. Others Segment Held Largest Share of Drug Class Segment in North America Branded Generics Market
Figure 5. Mexico is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints on North America Branded Generics Market
Figure 9. North America Branded Generics Market - By Country Forecast and Analysis - 2019 - 2028
Figure 10. North America Branded Generics Market Revenue Share, By Therapeutic Application: Market Analysis and Forecast 2022 and 2028 (%)
Figure 11. North America Oncology Market Revenue and Forecast to 2028 (US$ Billion)
Figure 12. North America Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 13. North America Diabetes Market Revenue and Forecast to 2028 (US$ Billion)
Figure 14. North America Neurology Market Revenue and Forecast to 2028 (US$ Billion)
Figure 15. North America Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 16. North America Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)
Figure 17. North America Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)
Figure 18. North America Others Market Revenue and Forecast to 2028 (US$ Billion)
Figure 19. North America Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 20. North America Hospital Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 21. North America Retail Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 22. North America Online Pharmacies: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 23. North America Drug Stores: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 24. North America Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)
Figure 25. North America Alkylating Agents: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 26. North America Antimetabolites: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 27. North America Hormones: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 28. North America Anti-hypertensive: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 29. North America Lipid Lowering Drugs: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 30. North America Anti-Depressants: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 31. North America Anti-psychotics: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 32. North America Anti-epileptic: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 33. North America Others: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 34. North America Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)
Figure 35. North America Oral Market Revenue and Forecast to 2028 (US$ Billion)
Figure 36. North America Parenteral Market Revenue and Forecast to 2028 (US$ Billion)
Figure 37. North America Topical Market Revenue and Forecast to 2028 (US$ Billion)
Figure 38. North America Others Market Revenue and Forecast to 2028 (US$ Billion)
Figure 39. North America: Branded Generics Market, by Key Country - Revenue (2022) (US$ Billion)
Figure 40. North America: Branded Generics Market, by Country, 2022 & 2028 (%)
Figure 41. US: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 42. Canada: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 43. Mexico: Branded Generics Market - Revenue and Forecast to 2028 (US$ Billion)
Figure 44. Growth Strategies Done by the Companies in the Market (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security